Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by University of California, San Francisco
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Priscilla Hsue, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01519141
First received: January 12, 2012
Last updated: June 3, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2018
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)